Literature DB >> 21960280

Application of a chiral metal-organic framework in enantioselective separation.

Mohan Padmanaban1, Philipp Müller, Christian Lieder, Kristina Gedrich, Ronny Grünker, Volodymyr Bon, Irena Senkovska, Sandra Baumgärtner, Sabine Opelt, Silvia Paasch, Eike Brunner, Frank Glorius, Elias Klemm, Stefan Kaskel.   

Abstract

A modular approach for the synthesis of highly ordered porous and chiral auxiliary (Evans auxiliary) decorated metal-organic frameworks is developed. Our synthesis strategy, which uses known porous structures as model materials for incorporation of chirality via linker modification, can provide access to a wide range of porous materials suitable for enantioselective separation and catalysis. Chiral analogues of UMCM-1 have been synthesized and investigated for the enantioseparation of chiral compounds in the liquid phase and first promising results are reported.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960280     DOI: 10.1039/c1cc14893a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

Review 1.  Metal-Organic Frameworks for Liquid Phase Applications.

Authors:  Anjaiah Nalaparaju; Jianwen Jiang
Journal:  Adv Sci (Weinh)       Date:  2021-01-21       Impact factor: 16.806

Review 2.  Metal-organic frameworks and self-assembled supramolecular coordination complexes: comparing and contrasting the design, synthesis, and functionality of metal-organic materials.

Authors:  Timothy R Cook; Yao-Rong Zheng; Peter J Stang
Journal:  Chem Rev       Date:  2012-11-02       Impact factor: 60.622

3.  Enantioselective Recognition of Ammonium Carbamates in a Chiral Metal-Organic Framework.

Authors:  Jeffrey D Martell; Leo B Zasada; Alexander C Forse; Rebecca L Siegelman; Miguel I Gonzalez; Julia Oktawiec; Tomče Runčevski; Jiawei Xu; Monika Srebro-Hooper; Phillip J Milner; Kristen A Colwell; Jochen Autschbach; Jeffrey A Reimer; Jeffrey R Long
Journal:  J Am Chem Soc       Date:  2017-10-25       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.